Rashid Lui, clinical assistant professor and specialist in gastroenterology and hepatology at the Chinese University of Hong Kong, shared news regarding the publication of a new Asia-Pacific consensus on the application of Artificial Intelligence in colorectal cancer screening and surveillance. The consensus has been authored by Frederick H. Koh and colleagues, reflecting collaboration among experts across the Asia-Pacific region.
This consensus aims to provide evidence-based recommendations for the use of Artificial Intelligence to improve early detection and monitoring of colorectal cancer, a leading cause of cancer-related deaths. The guidelines draw from the latest research and clinical trials across the region, emphasizing the potential of Artificial Intelligence to enhance the sensitivity and accuracy of colorectal cancer screenings, particularly through image analysis during colonoscopies and other diagnostic procedures.
The collaboration comes at a critical time when the integration of advanced technologies in healthcare is rapidly evolving. By establishing unified guidelines, the Asia-Pacific medical community seeks to ensure effective, safe, and equitable implementation of Artificial Intelligence tools in clinical settings. The consensus also addresses challenges such as data privacy, standardization, and the need for continued evaluation of these technologies as they are adopted in real-world practice. The publication is regarded as a milestone, setting a benchmark for further research and policy development in the application of Artificial Intelligence for cancer care in the region.
